Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Kronos Bio, Inc. (KRON) had Cash Flow from Financial Activities of $0.57M for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$6.29M |
|
$-112.67M |
|
-- |
|
$6.29M |
|
$128.12M |
|
$-121.83M |
|
$9.16M |
|
$-112.67M |
|
$-112.67M |
|
$-112.67M |
|
$-112.67M |
|
$-112.67M |
|
$-112.67M |
|
$-121.83M |
|
$-122.12M |
|
57.74M |
|
57.74M |
|
$-1.95 |
|
$-1.95 |
|
| Balance Sheet Financials | |
$178.78M |
|
$10.25M |
|
$34.50M |
|
$213.28M |
|
$24.70M |
|
-- |
|
$29.51M |
|
$54.20M |
|
$159.08M |
|
$159.08M |
|
$159.08M |
|
58.95M |
|
| Cash Flow Statement Financials | |
$-78.58M |
|
$66.37M |
|
|
Cash Flow from Financial Activities |
$0.57M |
$78.00M |
|
$66.35M |
|
$-11.65M |
|
$24.98M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-1937.50% |
|
-1937.50% |
|
-1942.10% |
|
-1791.87% |
|
-1791.87% |
|
$-79.26M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
-- |
|
-- |
|
-70.83% |
|
-70.83% |
|
-52.83% |
|
-70.83% |
|
$2.70 |
|
$-1.37 |
|
$-1.36 |
|